Home | Business News | Browse by Publication | B | Business Wire

ATEL Ventures Infuses $4.5MM of Growth Capital and Equity Financing Into Adenosine Therapeutics.

Publication: Business Wire
Publication Date: 30-NOV-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
New Arrangement Enables Further Rapid Growth

SAN FRANCISCO -- ATEL Ventures, Inc., a provider of secured financing to emerging growth companies, has released $4.5 million in growth capital financing to Adenosine Therapeutics, LLC, a company that has been leading the way in the discovery and development of adenosine receptor selective drug candidates since 1999. ATEL Venture's debt and equity financing...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
MMX Clarifies Press Statements Released Today., November 30, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.